LONDON-A new study published in The Lancet reports rectal cancer patients who undergo radiotherapy have less of a risk of local recurring cancer. They are also less likely to die from rectal cancer than other patients who chose to not have radiation therapy.
The study, conducted by researchers at the University of Birmingham in the UK, examined 8507 patients with rectal cancer. They found that while the overall survival of those patients who underwent radiation therapy was only slightly higher, they did have a 46% less likely chance of recurring cancer than patients who opted for surgery alone.
Patients who chose to radiotherapy were also found to be less likely to die from their disease than patients who only had surgery to treat their cancer.
Information from www.givenimaging.com, Reuters Health
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.